Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
Oncotarget2018Vol. 9(27), pp. 19006–19013
Citations Over TimeTop 10% of 2018 papers
Adam E. Frampton, Mireia Mato Prado, Elena López‐Jiménez, Ana Belen Fajardo-Puerta, Zaynab Jawad, Phillip Lawton, Elisa Giovannetti, Nagy Habib, Leandro Castellano, Justin Stebbing, Jonathan Krell, Long R. Jiao
Abstract
High GPC1 crExos may be able to determine PDAC tumor size and disease burden. However, further efforts are needed to elucidate its role as a diagnostic and/or prognostic biomarker using larger cohorts of PDAC patients.
Related Papers
- → Exosomes(2014)213 cited
- → Exosomes and communication between tumours and the immune system: are all exosomes equal?(2013)128 cited
- → A Comprehensive Review on Exosomes and Microvesicles as Epigenetic Factors(2016)47 cited
- → Announcing Exosomes and Microvesicles, the Official Journal of the American Society for Exosomes and Microvesicles(2013)1 cited
- → Microvesicles and Exosomes in Cancer(2014)